Saiful Islam: Laboratory Spot Check – Microcytic Anemias and The Thalassemia Spectrum
Saiful Islam, Lab TA 2 at Inova Fairfax Hospital, shared a post on LinkedIn:
“Laboratory Spot Check: Microcytic Anemias and The Thalassemia Spectrum
In clinical hematology, distinguishing microcytic anemias requires looking beyond basic indices to assess peripheral blood morphology and hemoglobin electrophoresis profiles.
Here is a quick refresher on key differentiators when evaluating Thalassemia Minor vs. Thalassemia Major:
Thalassemia Minor (Trait)
- Presentation: Mild anemia (typically \text{Hb} > 10\text{ g/dL}), microcytosis, and mild hypochromia.
- Red Cell Count: Characteristically elevated relative to the degree of anemia, often alongside a normal RDW.
- Morphology: Target cells and basophilic stippling are commonly observed.
Key Diagnostic Findings:
- In \beta-thalassemia trait, elevated Hemoglobin A2 (\text{HbA}_2) levels are standard.
- In \alpha-thalassemia trait, confirmation relies on ruling out other causes of microcytic anemia, globin chain synthesis ratios (\alpha/\beta < 1.0), or molecular genetic testing.
Thalassemia Major
- Presentation: Severe microcytic, hypochromic anemia (frequently \text{Hb} < 7\text{ g/dL}).
- Morphology: Marked anisocytosis and poikilocytosis, target cells, basophilic stippling, and circulating normoblasts. In post-splenectomy patients, inclusions such as Howell-Jolly bodies, Pappenheimer bodies, and Fessas bodies (precipitated excess \alpha-chains) are frequently visualized.
Electrophoresis Profiles:
- /beta^0-thalassemia major: marked elevation of \text{HbF} (94\% \text{–} 98\%), absence of \text{HbA}.
- /beta^+-thalassemia: predominant \text{HbF} (70\% \text{–} 80\%) with residual \text{HbA} (10\% \text{–} 30\%).
A key diagnostic reminder for the lab: interpreting hemoglobin electrophoresis and smear morphology in severe thalassemias can be complicated by periodic transfusion history—always verify patient clinical history when reviewing unexpected profiles!
What red cell morphology clues do you find most distinct when differentiating microcytic anemias in your laboratory workflow?”

Stay updated with Hemostasis Today.
-
Oct 12, 2026, 06:45Nick Lenamon: Stroke Awareness at Any Age Recognizing the Signs and Acting FAST
-
Oct 12, 2026, 04:45Aparna Korisetty: Upper GI Bleeding and Severe Anemia Secondary to Duodenal NET
-
Oct 12, 2026, 04:38Aya AlFakih: Why HbA1c Can Be High even When this Morning’s Glucose Looks Normal?
-
Oct 11, 2026, 22:40Bahram Alamdary Badlou: Platelets as First Responders in Hemostasis, Immunity, and Inflammation
-
Oct 11, 2026, 22:22Vipin Singh: New Publication on Hippo-YAP Signaling and Platelet Activation
-
Oct 11, 2026, 22:21Trygve Berge: New AFNOR Paper on AF-related Stroke in Norway
-
Oct 11, 2026, 22:09Omar Alomari: Our New Publication on Apixaban vs Rivaroxaban for VTE
-
Oct 11, 2026, 21:22Shayan Roshan: Happy to Share Two Research Milestones in Trauma Care and Pancreatic Cancer
-
Oct 11, 2026, 21:16Chokri Ben Lamine: Anemia in Myelofibrosis – Multiple Mechanisms, Limited Responses